ProShare Advisors’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $227K | Sell |
9,121
-999
| -10% | -$24.9K | ﹤0.01% | 1642 |
|
|
2025
Q1 | $314K | Sell |
10,120
-2,836
| -22% | -$87.9K | ﹤0.01% | 1381 |
|
|
2024
Q4 | $409K | Buy |
12,956
+3,996
| +45% | +$126K | ﹤0.01% | 1403 |
|
|
2024
Q3 | $519K | Buy |
8,960
+2,303
| +35% | +$133K | ﹤0.01% | 1110 |
|
|
2024
Q2 | $270K | Sell |
6,657
-2,061
| -24% | -$83.6K | ﹤0.01% | 1362 |
|
|
2024
Q1 | $366K | Buy |
8,718
+703
| +9% | +$29.5K | ﹤0.01% | 1288 |
|
|
2023
Q4 | $307K | Buy |
8,015
+1,513
| +23% | +$57.9K | ﹤0.01% | 1351 |
|
|
2023
Q3 | $201K | Sell |
6,502
-122
| -2% | -$3.76K | ﹤0.01% | 1466 |
|
|
2023
Q2 | $209K | Buy |
6,624
+975
| +17% | +$30.8K | ﹤0.01% | 1511 |
|
|
2023
Q1 | $206K | Buy |
+5,649
| New | +$206K | ﹤0.01% | 1429 |
|
|
2022
Q4 | – | Sell |
-5,361
| Closed | -$209K | – | 1896 |
|
|
2022
Q3 | $209K | Sell |
5,361
-105
| -2% | -$4.09K | ﹤0.01% | 1387 |
|
|
2022
Q2 | $212K | Sell |
5,466
-2,919
| -35% | -$113K | ﹤0.01% | 1438 |
|
|
2022
Q1 | $406K | Sell |
8,385
-1,038
| -11% | -$50.3K | ﹤0.01% | 1429 |
|
|
2021
Q4 | $693K | Buy |
9,423
+3,622
| +62% | +$266K | ﹤0.01% | 1243 |
|
|
2021
Q3 | $528K | Sell |
5,801
-3,968
| -41% | -$361K | ﹤0.01% | 1180 |
|
|
2021
Q2 | $614K | Buy |
+9,769
| New | +$614K | ﹤0.01% | 1377 |
|